PREVEST.BO · BSE
Prevest Denpro Limited
₹377.2
-0.47% (-₹1.8)
Prev. close
₹379
Volume
7,000
As of
BSE · may be slightly delayed · 16:00 IST
Price history
No analyst calls on this stock in the last 90 days yet.
Explore by date range →Analyst opinions
Fundamentals
About Prevest Denpro Limited
Prevest Denpro Limited, together with its subsidiaries, engages in the manufacturing and marketing of dental materials and allied products. The company offers clinical products, including adhesives, bonding agents, and etchants; auxiliaries; cement and liners; composites; endodontics; finishing and polishing; impression; orthodontics; retraction materials; temporaries; and tooth whitening products. It also provides laboratory products, such as acrylics, auxiliaries, base plates and waxes, and gypsum products; 3D resins; oral care; and hygiene and disinfection products. The company's products are used in endodontics, prosthodontics, periodontics, orthodontics, restorative dentistry, and aesthetic dentistry applications, as well as for fabrication of prosthesis in dental laboratories. Prevest Denpro Limited was incorporated in 1999 and is based in Jammu, India.
Details
Sector
Healthcare
Industry
Medical Instruments & Supplies
CEO
Mr. Atul Modi
Headquarters
Jammu
Employees
139
Website
prevestdenpro.comExchange
View on BSE ↗Key stats
Market cap
₹454.91 Cr
P/E ratio (TTM)
21.0
Dividend yield
0.26%
EPS (TTM)
₹18.08
Beta (1Y · daily vs NIFTY 50)
0.76
Beta (5Y · monthly vs NIFTY 50)
2.06
Shares float
21.71 L
EPS · quarter ended Jun 2026
₹4.70
Financial Performance
01 · Financials
The first plotted growth figure is computed against Mar 2022 revenue as filed with BSE; the two sources' revenue definitions differ by 0.0% on Mar 2023. FY23 growth needs FY22 filings, which the data source doesn't provide.
02 · Earnings Per Share (EPS)
03 · Dividend Profile
Growth compares completed fiscal-year dividend totals on the company's own calendar: April–March (Indian FY), taken from its reported period-ends. Payout ledger: Yahoo (no NSE corporate-actions ledger for this listing).
04 · Operating Efficiency (Growth Rates)
Balance-sheet-based · pre-FY23 not filed in verifiable form
05 · Capital Structure & Asset Utilization
Pre-FY23 not filed in verifiable form
Asset turnover needs a prior year of assets — omitted for the earliest available year.
06 · Asset Base Composition
Pre-FY23 not filed in verifiable form
Other assets floored at zero for years where fixed and current assets exceeded reported total assets.
07 · Debt Level & Coverage
Pre-FY23 not filed in verifiable form
08 · Profit & Loss
Annual
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| ₹37.62 Cr | ₹49.85 Cr | ₹55.91 Cr | ₹62.08 Cr | ₹70.89 Cr | |
| EBITDA | — | ₹21.63 Cr | ₹22.71 Cr | ₹26.15 Cr | ₹29.62 Cr |
| ₹11.57 Cr | ₹15.71 Cr | ₹16.14 Cr | ₹18.16 Cr | ₹20.49 Cr | |
| Diluted EPS | ₹9.64 | ₹13.09 | ₹13.45 | ₹15.13 | ₹17.07 |
Depreciation & amortisation, EBITDA, Pretax income, Tax provision, Interest expense have filed figures for only some of the years shown — the missing years are left blank rather than estimated.
09 · Balance Sheet
Annual
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| — | ₹7.41 Cr | ₹94.82 Cr | ₹112.53 Cr | ₹133.19 Cr | |
| — | ₹0 | ₹0 | ₹0 | ₹0 | |
| Stockholders' equity | — | ₹72.80 Cr | ₹88.62 Cr | ₹105.57 Cr | ₹124.80 Cr |
Total assets, Current assets, Trade receivables, Cash & equivalents, Non-current assets, Fixed assets, Total debt, Long-term debt, Current (short-term) debt, Others, Stockholders' equity have filed figures for only some of the years shown — the missing years are left blank rather than estimated.
Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.
10 · Cash Flow Statement
Annual
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| — | ₹10.67 Cr | ₹11.62 Cr | ₹14.82 Cr | ₹14.81 Cr | |
| Investing cash flow | — | ₹-12.38 Cr | ₹-1.70 Cr | ₹-1.33 Cr | ₹-1.59 Cr |
| — | ₹-1.37 Cr | ₹-31.68 L | ₹-1.20 Cr | ₹-1.20 Cr | |
| Capital expenditure | — | ₹-13.53 Cr | ₹-3.73 Cr | ₹-1.97 Cr | ₹-1.89 Cr |
| End cash position | — | ₹39.00 Cr | ₹48.61 Cr | ₹60.90 Cr | ₹72.85 Cr |
Operating cash flow, Depreciation & amortization, Change in working capital, Investing cash flow, Financing cash flow, Dividends paid, Capital expenditure, End cash position have filed figures for only some of the years shown — the missing years are left blank rather than estimated.
Annual only — the data source has no quarterly cash-flow-statement coverage.
12 · Peer Comparison
Healthcare
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4.48 L Cr | ₹1,846.4 | 37.1 | 5.37 | 13.7% | 0.06 | +11.9% | +12.3% |
| Divi's Laboratories Limited | ₹2.49 L Cr | ₹9,410.5 | 84.7 | 14.85 | 15.3% | 0.00 | +12.3% | +51.8% |
| Torrent Pharmaceuticals Limited | ₹1.84 L Cr | ₹4,970 | 77.5 | 21.95 | 25.8% | 1.79 | +21.5% | +36.9% |
| Apollo Hospitals Enterprise Limited | ₹1.28 L Cr | ₹8,835.5 | 61.5 | 13.52 | 20.5% | 0.90 | +15.7% | +14.2% |
| Lenskart Solutions Limited | ₹1.18 L Cr | ₹691.45 | 179.0 | 13.55 | 5.6% | 0.35 | +35.4% | — |
| Zydus Lifesciences Limited | ₹1.16 L Cr | ₹1,161 | 25.8 | 4.27 | 18.6% | 0.46 | +18.4% | +11.9% |
| Cipla Limited | ₹1.12 L Cr | ₹1,384.1 | 33.2 | 3.25 | 11.3% | 0.02 | +2.1% | -10.3% |
| Laurus Labs Limited | ₹1.09 L Cr | ₹2,006.5 | 99.3 | 20.57 | 16.8% | 0.48 | +22.0% | +122.0% |
| Max Healthcare Institute Limited | ₹1.02 L Cr | ₹1,066.6 | 70.4 | 9.50 | 13.4% | 0.32 | +19.0% | -8.0% |
| Manipal Health Enterprises Limited | ₹99,047.90 Cr | ₹746.1 | 152.1 | 11.75 | 7.8% | 1.53 | +18.0% | — |
| Dr. Reddy's Laboratories Limited | ₹98,709.15 Cr | ₹1,198.3 | 29.8 | 2.62 | 11.4% | 0.21 | +3.2% | -9.3% |
| Prevest Denpro Limited | ₹459.71 Cr | ₹382.3 | 21.2 | 3.68 | 16.4% | 0.00 | +14.2% | -32.2% |
Ranked by market cap within Healthcare, same metrics as the Fundamentals screener. Click a column to sort.
Documents
Annual reports
Concall transcripts
Official documents linked from their sources — offer documents as filed with SEBI (sebi.gov.in), annual reports and earnings-call transcripts as published on BSE (bseindia.com) and NSE (nseindia.com). Links open the source's own hosting; nothing is re-hosted here.